STAR:NSE
Strides Pharma Science Ltd
962,40 ₹
arrow_downward
-1,71%(-16,70) 1 d.
20. nov., 15:30:00 GMT+5:30 · INR
search
Visi simboli
| Simbols | Cena | Izmaiņas | % izmaiņu |
|---|
insights_autoNotiek galveno ieskatu ģenerēšana par šādu tēmu: STAR…
Atvērt
982,00 ₹
Augsta
982,00 ₹
Zema
956,10 ₹
Tirgus kapitalizācija
88,71 mljrd.
Vid. apjoms
365,19 tūkst.
Apjoms
232,62 tūkst.
Dividende
0,52%
Ceturkšņa dividendes
1,25 ₹
Datums, kad tiek pārtraukta dividenžu izmaksa
2026. gada 31. jūl.
Cenas/peļņas attiecība
14,39
Augstākā 52 ned.
1 260,90 ₹
Zemākā 52 ned.
768,65 ₹
Peļņa uz vienu akciju
66,90 ₹
Apgrozībā esošās akcijas
89,55 milj.
Darbinieku skaits
4 tūkst.
Atvērt
982,00 ₹
Augsta
982,00 ₹
Zema
956,10 ₹
Tirgus kapitalizācija
88,71 mljrd.
Vid. apjoms
365,19 tūkst.
Apjoms
232,62 tūkst.
Dividende
0,52%
Ceturkšņa dividendes
1,25 ₹
Datums, kad tiek pārtraukta dividenžu izmaksa
2026. gada 31. jūl.
Cenas/peļņas attiecība
14,39
Augstākā 52 ned.
1 260,90 ₹
Zemākā 52 ned.
768,65 ₹
Peļņa uz vienu akciju
66,90 ₹
Apgrozībā esošās akcijas
89,55 milj.
Darbinieku skaits
4 tūkst.
Ziņas un raksti
No tīmekļa avotiem un ziņu partneriem
AP News
·
pirms 13 stundām
S&P 500 sinks 3.7% and Nasdaq composite goes negative for the year as tech sell-off worsens
Trefis
·
pirms 4 stundām
25 S&P 500 Stocks Just Made New 52-Week Lows
Beinsure
·
pirms 3 stundām
S&P 500 forecast for 2027: Wall Street expects a rebound after an 11.6% drop fueled by AI fears
Yahoo Finance
·
pirms 16 stundām
Wall St ends sharply lower on AI selloff, S&P 500, Dow in correction
Profils
Strides Pharma Science Limited is an Indian pharmaceutical company, headquartered at Bangalore. The company manufactures pharmaceutical products, over-the-counter drugs and nutraceuticals. Products include softgel capsules, hard-gel capsules, tablets and dry and wet injectables. The company has 15 manufacturing sites in six countries and marketing presence in 50 countries. The company partners with generic companies to supply retail and hospital generics in injectable products and softgels. The company's stock trades on the Bombay Stock Exchange and on the National Stock Exchange of India.
Strides Arcolab changed name to Strides Shasun Ltd after an amalgamation of Shasun Pharmaceuticals with Strides Arcolab. In September 2014, the Board of Directors of both the companies had approved a scheme of amalgamation between the two companies.
Arun Kumar is the founder and chairman, and has been on the board as managing director since its inception. Wikipedia
Par “Strides Pharma Science Ltd”
Ģenerāldirektors-
Darbinieki3,54 tūkst.
Dibināšanas datums1990
Galvenais birojsBengalūru, Karnātaka, Indija
SektorsHealth Care
Nozare-
Tīmekļa vietnestrides.com